Log in

X T L Biopharmaceuticals Stock Price, News & Analysis (NASDAQ:XTLB)

$1.67
0.00 (0.00 %)
(As of 10/16/2019 08:25 AM ET)
Today's Range
$1.67
Now: $1.67
$1.67
50-Day Range
$1.38
MA: $1.77
$1.95
52-Week Range
$1.37
Now: $1.67
$3.86
VolumeN/A
Average Volume3,799 shs
Market Capitalization$8.60 million
P/E Ratio1.46
Dividend YieldN/A
Beta1.08
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:XTLB
CUSIPN/A
Phone972-9955-7080

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash Flow$0.58 per share
Book Value$1.62 per share

Profitability

Net Income$2.99 million

Miscellaneous

EmployeesN/A
Market Cap$8.60 million
Next Earnings Date11/7/2019 (Estimated)
OptionableNot Optionable

Receive XTLB News and Ratings via Email

Sign-up to receive the latest news and ratings for XTLB and its competitors with MarketBeat's FREE daily newsletter.


X T L Biopharmaceuticals (NASDAQ:XTLB) Frequently Asked Questions

What is X T L Biopharmaceuticals' stock symbol?

X T L Biopharmaceuticals trades on the NASDAQ under the ticker symbol "XTLB."

When did X T L Biopharmaceuticals' stock split? How did X T L Biopharmaceuticals' stock split work?

Shares of X T L Biopharmaceuticals reverse split on Friday, February 10th 2017. The 1-5 reverse split was announced on Wednesday, January 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 9th 2017. An investor that had 100 shares of X T L Biopharmaceuticals stock prior to the reverse split would have 20 shares after the split.

When is X T L Biopharmaceuticals' next earnings date?

X T L Biopharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for X T L Biopharmaceuticals.

Has X T L Biopharmaceuticals been receiving favorable news coverage?

Media coverage about XTLB stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. X T L Biopharmaceuticals earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the biopharmaceutical company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the company's share price in the near future. View News Stories for X T L Biopharmaceuticals.

Who are some of X T L Biopharmaceuticals' key competitors?

What other stocks do shareholders of X T L Biopharmaceuticals own?

Who are X T L Biopharmaceuticals' key executives?

X T L Biopharmaceuticals' management team includes the folowing people:
  • Mr. Joshua Levine, Chief Exec. Officer (Age 53)
  • Mr. Itay Weinstein, Chief Financial Officer (Age 48)
  • Mr. Ronen Kantor Adv, Company Sec.

How do I buy shares of X T L Biopharmaceuticals?

Shares of XTLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is X T L Biopharmaceuticals' stock price today?

One share of XTLB stock can currently be purchased for approximately $1.67.

How big of a company is X T L Biopharmaceuticals?

X T L Biopharmaceuticals has a market capitalization of $8.60 million. View Additional Information About X T L Biopharmaceuticals.

What is X T L Biopharmaceuticals' official website?

The official website for X T L Biopharmaceuticals is http://www.xtlbio.com/.

How can I contact X T L Biopharmaceuticals?

X T L Biopharmaceuticals' mailing address is 5 HACHAROSHET ST., RAANANA L3, 43656. The biopharmaceutical company can be reached via phone at 972-9955-7080 or via email at [email protected]


MarketBeat Community Rating for X T L Biopharmaceuticals (NASDAQ XTLB)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  123
MarketBeat's community ratings are surveys of what our community members think about X T L Biopharmaceuticals and other stocks. Vote "Outperform" if you believe XTLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XTLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel